Page last updated: 2024-10-27

fluoxetine and Prostatic Diseases

fluoxetine has been researched along with Prostatic Diseases in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Prostatic Diseases: Pathological processes involving the PROSTATE or its component tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, S1
Pandey, D1
Mandalapu, D1
Sharma, V1
Shukla, M1
Singh, S2
Singh, N1
Yadav, SK1
Tanpula, DK1
Maikhuri, JP1
Shukla, S1
Lal, J1
Siddiqi, MI1
Gupta, G1
Sharma, VL1

Other Studies

1 other study available for fluoxetine and Prostatic Diseases

ArticleYear
Novel aryl piperazines for alleviation of 'andropause' associated prostatic disorders and depression.
    European journal of medicinal chemistry, 2017, May-26, Volume: 132

    Topics: Androgen Antagonists; Andropause; Animals; Cell Line; Depression; Down-Regulation; Humans; Male; Mol

2017